Production (Stage)
Replimune Group, Inc.
REPL
$8.98
-$0.39-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.57M | 18.21M | 15.70M | 14.62M | 16.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.78M | 65.64M | 58.51M | 56.93M | 58.09M |
| Operating Income | -78.78M | -65.64M | -58.51M | -56.93M | -58.09M |
| Income Before Tax | -74.24M | -65.77M | -53.06M | -53.77M | -55.14M |
| Income Tax Expenses | -107.00K | 575.00K | -- | -- | -65.00K |
| Earnings from Continuing Operations | -74.13M | -66.34M | -53.06M | -53.77M | -55.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.13M | -66.34M | -53.06M | -53.77M | -55.08M |
| EBIT | -78.78M | -65.64M | -58.51M | -56.93M | -58.09M |
| EBITDA | -77.53M | -64.95M | -57.68M | -56.19M | -57.38M |
| EPS Basic | -0.82 | -0.79 | -0.78 | -0.79 | -0.83 |
| Normalized Basic EPS | -0.51 | -0.49 | -0.48 | -0.49 | -0.52 |
| EPS Diluted | -0.82 | -0.79 | -0.78 | -0.79 | -0.83 |
| Normalized Diluted EPS | -0.51 | -0.49 | -0.48 | -0.49 | -0.52 |
| Average Basic Shares Outstanding | 90.92M | 83.50M | 68.39M | 68.31M | 66.68M |
| Average Diluted Shares Outstanding | 90.92M | 83.50M | 68.39M | 68.31M | 66.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |